3.20. Analysis.
Comparison 3: Dihydroartemisinin‐piperaquine (DHA‐PPQ) plus daily cotrimoxazole (CTXp) versus placebo plus CTXp, Outcome 20: Adverse events: headache
Comparison 3: Dihydroartemisinin‐piperaquine (DHA‐PPQ) plus daily cotrimoxazole (CTXp) versus placebo plus CTXp, Outcome 20: Adverse events: headache